Abstract
Prion diseases are zoonotic infectious diseases caused by infectious particles, termed prions. Main component of prions is presumably a misfolded, partially protease-resistant conformer (PrPSc) of a normal cell surface protein, the cellular prion protein (PrPC), whose anti-oxidative role is presumed by studies using prion protein (PrP)-knockout mice and cell lines. Major common features of prion diseases are PrPSc deposition, astrocytosis, and vacuolation, but the presence of these features and transmission route are dependent on the combination of prion strain and host species. Generally, prions replicate first in the lymphoreticular system, although the presence of PrPSc within lymphoid tissues seems to be dependent on factors such as route of prion exposure or type of prion strain. After that, prions travel to the brain via neuronal pathways along peripheral nerves, where their conversion leads to the accumulation of PrPSc and a deficiency of PrPC, contributing etiologically to the death of neurons including apoptosis and autophagy. In this review, we provide an overview of current information on PrPC and PrPSc as well as their involvement in the pathogenesis of prion diseases.
Keywords: Anti-oxidation, apoptosis, autophagy, oxidative stress, prion disease, prion protein, reactive oxygen species, transmissible spongiform encephalopathy
Current Medicinal Chemistry
Title: Prion Protein Functions and Dysfunction in Prion Diseases
Volume: 16 Issue: 3
Author(s): Akikazu Sakudo and Kazuyoshi Ikuta
Affiliation:
Keywords: Anti-oxidation, apoptosis, autophagy, oxidative stress, prion disease, prion protein, reactive oxygen species, transmissible spongiform encephalopathy
Abstract: Prion diseases are zoonotic infectious diseases caused by infectious particles, termed prions. Main component of prions is presumably a misfolded, partially protease-resistant conformer (PrPSc) of a normal cell surface protein, the cellular prion protein (PrPC), whose anti-oxidative role is presumed by studies using prion protein (PrP)-knockout mice and cell lines. Major common features of prion diseases are PrPSc deposition, astrocytosis, and vacuolation, but the presence of these features and transmission route are dependent on the combination of prion strain and host species. Generally, prions replicate first in the lymphoreticular system, although the presence of PrPSc within lymphoid tissues seems to be dependent on factors such as route of prion exposure or type of prion strain. After that, prions travel to the brain via neuronal pathways along peripheral nerves, where their conversion leads to the accumulation of PrPSc and a deficiency of PrPC, contributing etiologically to the death of neurons including apoptosis and autophagy. In this review, we provide an overview of current information on PrPC and PrPSc as well as their involvement in the pathogenesis of prion diseases.
Export Options
About this article
Cite this article as:
Sakudo Akikazu and Ikuta Kazuyoshi, Prion Protein Functions and Dysfunction in Prion Diseases, Current Medicinal Chemistry 2009; 16 (3) . https://dx.doi.org/10.2174/092986709787002673
DOI https://dx.doi.org/10.2174/092986709787002673 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Heat Shock Protein (HSP) in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Medicinal Chemistry Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry Reprogramming Cancer Cells in Endocrine-Related Tumors: Open Issues
Current Medicinal Chemistry Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) – a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Disposition of Vorinostat, A Novel Histone Deacetylase Inhibitor and Anticancer Agent, in Preclinical Species
Drug Metabolism Letters Graphical Abstracts
Letters in Drug Design & Discovery Natural New Sesquiterpenes: Structural Diversity and Bioactivity
Current Organic Chemistry Methods for Hydroxamic Acid Synthesis
Current Organic Chemistry Opportunities to Exploit Non-Neutralizing HIV-Specific Antibody Activity
Current HIV Research Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist
Current Topics in Medicinal Chemistry Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Current Pharmaceutical Design From Natural Products to Designer Drugs: Development and Molecular Mechanisms Action of Novel Anti-Microtubule Breast Cancer Therapeutics
Current Topics in Medicinal Chemistry Cancer Regulator MicroRNA: Potential Relevance in Diagnosis, Prognosis and Treatment of Cancer
Current Medicinal Chemistry Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma
Current Pharmaceutical Biotechnology The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development
Current Bioactive Compounds Tubulin-Targeting Agents in Hybrid Drugs
Current Medicinal Chemistry Fluorescein-labeled Bacitracin and Daptomycin Conjugates: Synthesis, Fluorescence Imaging and Evaluation
Medicinal Chemistry Bench to Bedside Targeting of FLT3 in Acute Leukemia
Current Drug Targets Oncolytic Viruses Driven by Tumor-Specific Promoters
Current Cancer Drug Targets